Anne Motsenbocker Net Worth

The estimated Net Worth of Anne Motsenbocker is at least $216 Tisíc dollars as of 9 August 2022. Anne Motsenbocker owns over 500 units of U.S. Physical Therapy stock worth over $216,008 and over the last 3 years Anne sold USPH stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Anne Motsenbocker USPH stock SEC Form 4 insiders trading

Anne has made over 1 trades of the U.S. Physical Therapy stock since 2022, according to the Form 4 filled with the SEC. Most recently Anne bought 500 units of USPH stock worth $46,145 on 9 August 2022.

The largest trade Anne's ever made was buying 500 units of U.S. Physical Therapy stock on 9 August 2022 worth over $46,145. On average, Anne trades about 63 units every 0 days since 2022. As of 9 August 2022 Anne still owns at least 2,600 units of U.S. Physical Therapy stock.

You can see the complete history of Anne Motsenbocker stock trades at the bottom of the page.

What's Anne Motsenbocker's mailing address?

Anne's mailing address filed with the SEC is 5420 LBJ FREEWAY, STE 500, , DALLAS, TX, 75240.

Insiders trading at U.S. Physical Therapy

Over the last 23 years, insiders at U.S. Physical Therapy have traded over $77,674,124 worth of U.S. Physical Therapy stock and bought 127,370 units worth $3,593,373 . The most active insiders traders include Bruce D Broussard, Roy W Spradlin a Christopher J Reading. On average, U.S. Physical Therapy executives and independent directors trade stock every 22 days with the average trade being worth of $787,765. The most recent stock trade was executed by Kathleen A Gilmartin on 3 September 2024, trading 2,000 units of USPH stock currently worth $172,180.

What does U.S. Physical Therapy do?

u.s. physical therapy is a publicly held company that operates hundreds of outpatient physical and occupational therapy clinics in over 40 states. the company's clinics provide acute, post-operative, and preventative care for a variety of orthopedic and neurologic disorders including sports and work related injuries. the unique nature of the company is its operating structure - the company's clinics are developed and operated through partnerships with therapists who share in the clinic's profits. in addition to the therapist partnership model, u.s. physical therapy also buys into existing physical therapy practices.

Complete history of Anne Motsenbocker stock trades at CSW Industrials Inc a U.S. Physical Therapy

U.S. Physical Therapy executives and stock owners

U.S. Physical Therapy executives and other stock owners filed with the SEC include:

• Christopher Reading,
  President, Chief Executive Officer, Director
• Lawrance McAfee,
  Director
• Graham Reeve,
  Chief Operating Officer - East
• Glenn McDowell,
  Chief Operating Officer - West
• Christopher J. Reading,
  Pres, CEO & Director
• Graham D. Reeve M.B.A., P.T.,
  Chief Operating Officer of East
• Glenn D. McDowell,
  Chief Operating Officer of West
• Carey P. Hendrickson,
  Chief Financial Officer
• Reginald Swanson,
  Director
• Clayton Trier,
  Independent Director
• Harry Chapman,
  Independent Director
• Edward Kuntz,
  Independent Chairman of the Board
• Bernard Harris,
  Independent Director
• Mark Brookner,
  Independent Director
• Kathleen Gilmartin,
  Independent Director
• Carey Hendrickson,
  Chief Financial Officer
• Jason Anderson,
  VP of HR
• Jayne Fleck Pool ATC, PT, SCS,
  Sr. VP & Chief Compliance Officer
• Chadd Pence,
  Sr. VP of Information Systems
• Jake Martinez,
  Sr. VP of Fin. & Accounting
• Johnny J. Blanchard,
  Assistant Controller
• Jon C. Bates,
  VP & Corp. Controller
• Eric Joseph Williams,
  Co-Chief Operating Officer - West
• Richard S. Binstein,
  Exec. VP, Gen. Counsel & Sec.
• Marlin W Johnston,
  Director
• Jerald L Pullins,
  Director
• Eric Joseph Williams,
  Co-Chief Operations Officer
• Regg E. Swanson,
  
• Anne Motsenbocker,
  
• Nancy Ham,
  
• Bruce D Broussard,
  Director
• James B Hoover,
  Director
• Daniel C Arnold,
  Director
• Albert L Rosen,
  Director
• J Livingston Kosberg,
  CEO and President
• Roy W Spradlin,
  Chairman, President, CEO
• Michael Lewis Lang,
  Sr. VP of Development
• Richard Binstein,
  EVP Gen'l Counsel & Secretary